Harmony Biosciences, LLC is a biopharmaceutical company dedicated to developing innovative therapies to help patients with unmet medical needs. Harmony is focused on providing novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. Harmony is headquartered in Plymouth Meeting, PA and also has offices in the Chicago, Illinois area.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/09/17 | $270,000,000 |
Fidelity Management & Research Company HBM Healthcare Investments Nan Fung Novo Holdings Valor Equity Partners VenBio Vivo Capital | undisclosed |
